A Slow Response But At Least A Response
I filed a petition with the FDA in 2014 to ban the Flouriquinolone Class of antibiotics from common prescription use. I requested it to have the label changed so that it is not used for everyday conditions, such as UTI, bronchitis, and similar diseases that are easily treatable by other antibiotics and which do not need a broad spectrum antibiotic. I recommended to have Fluroquinolones be reserved for life-and-death situations only when there are no alternatives and to change the label reflecting all adverse side effect that were already well understood, and to “blackbox” the medication. In my previous article on this subject, found here, I updated the FDA information, since new side effects made it imperative to immediately restrict all quinolones from common use. Why is this all interesting now? Because of a letter I just received from the FDA!
NIH Commentary for Nutrition Research
What Research Should Be Funded?
In November 2018 through December 15, 2018, the NIH invited public comments to guide the kind of research they will support for the next decade. This comment period was short but critical. Historically, the NIH has been influenced tremendously by business interests that provide huge chucks of financial support to the government and thereby to the NIH. Thus there has ever been any unbiased research funding for nutrition research. This may also be true of other research areas–I am no familiar with them.
I found it very important to submit my commentary, which I did on the 11th of December, so a few days before the deadline. Here I copy-paste my commentary so you can see what I see as weakness in the NIH funding process through my recommendations. There is no way to know if the NIH considers anyone’s recommendations at all. However, it cannot hurt to try. Right? Right. So here is my comment, which starts with the greeting letter. I copy-paste the whole thing. I also attach it in a PDF in case you want to download it–it is a public document now: NIH–comment–AAStanton–12-11-2018 Continue reading →
Share this:
Like this: